• Home
  • Posts Tagged'FEASIBILITY studies'

Posts Tagged ‘FEASIBILITY studies’

Bayes net classifiers for prediction of renal graft status and survival period






This paper presents the development of a Bayesian belief network classifier for prediction of graft status and survival period in renal transplantation using the patient profile information prior to the transplantation. The objective was to explore feasibility of developing a decision making tool for identifying the most suitable recipient among the candidate pool members. The dataset was compiled from the University of Toledo Medical Center Hospital patients as reported to the United Network Organ Sharing, and had 1228 patient records for the period covering 1987 through 2009. The Bayes net classifiers were developed using the Weka machine learning software workbench. Two separate classifiers were induced from the data set, one to predict the status of the graft as either failed or living, and a second classifier to predict the graft survival period. The classifier for graft status prediction performed very well with a prediction accuracy of 97.8% and true positive values of 0.967 and 0.988 for the living and failed classes, respectively. The second classifier to predict the graft survival period yielded a prediction accuracy of 68.2% and a true positive rate of 0.85 for the class representing those instances with kidneys failing during the first year following transplantation. Simulation results indicated that it is feasible to develop a successful Bayesian belief network classifier for prediction of graft status, but not the graft survival period, using the information in UNOS database. [ABSTRACT FROM AUTHOR]


Read More
 

Shortcut design of reactive distillation columns

Abstract: Shortcut design methods can be valuable tools for rapid screening of different separation process alternatives to assess feasibility and determine minimum energy demand. This work presents a variant of the feed angle method (), which applies to single- and double-feed reactive distillation columns. The proposed method relies on pinch point analysis and determines the minimum energy demand from the calculation of a tray at the feed pinch. It is fully algorithmic and insensitive to impurities in product specifications. Its validity and performance is illustrated by a variety of case studies covering multi-component and multi-reaction systems, mixtures with potential liquid–liquid phase split, and double-feed columns. The results show that the method is sufficiently accurate and computationally efficient, even for highly non-ideal systems and complex configurations. [Copyright &y& Elsevier]

Read More
 

Non-invasive prenatal determination of fetal gender using qf-pcr analysis of cell-free fetal dna in maternal plasma

Abstract: Background: Detection of cell-free fetal DNA (cffDNA) in maternal plasma has given rise to the possibility of new non-invasive approaches for early prenatal diagnoses. We evaluated the feasibility and accuracy of non-invasive fetal gender determination using quantitative fluorescent-polymerase chain reaction (QF-PCR) analysis of circulating cffDNA in the first-trimester maternal plasma. Methods: Plasma samples were prospectively collected from 202 singleton pregnancies at 4 to 13weeks of gestation. Fetal gender was determined by QF-PCR with the sex-determining region Y (SRY) and amelogenin X/Y (AMELX/Y) genes. The result was confirmed by fetal karyotyping or phenotype at birth. Results: Of the 202 pregnancies, 162 had pregnancy outcomes available and could be included in our evaluation. The accuracies of AMELX/Y, SRY, and combined AMELX/Y + SRY analysis for fetal gender determination were 83.3%, 82.1%, and 97.5%, respectively, compared with those of the invasive approach and the fetal gender outcome at birth (82 males and 80 females). Combined AMELX/Y + SRY analysis had the highest sensitivity (98.8%) for fetal gender determination with a specificity of 96.3%. Moreover, fetal gender detection by the combined AMELX/Y + SRY analysis at 11 to 13weeks of gestation was 100% correct. Conclusion: Fetal gender determination could be accurately determined from maternal cffDNA in the first-trimester using QF-PCR analysis of combined AMELX/Y + SRY. [Copyright &y& Elsevier]

Read More
 

Tubeless vs standard percutaneous nephrolithotomy: a meta-analysis

Study Type – Therapy (case series) Level of Evidence 4 What’s known on the subject? and What does the study add? This study showed that tubeless PCNL could reduce hospital stay with little need for postoperative analgesia. This study discussed the clinical feasibility of tubeless PCNL, which is the tendency of PCNL. Our results are reliable by using veta-analysis from individual studies. OBJECTIVE [ABSTRACT FROM AUTHOR]

Read More
 

Development of intravenous lipid emulsion of tanshinone iia and evaluation of its anti-hepatoma activity in vitro

Abstract: The purpose of this study was to develop a lipid emulsion of tanshinone IIA (Tan IIA-LE) for intravenous administration and to investigate its feasibility for future clinical practice. The formulation was optimized using central composite design-response surface methodology (CCD-RSM), and the homogenization process was investigated systematically. The Tan IIA-LE was evaluated in terms of stability, safety and in vitro anti-hepatoma activity. The formulation of Tan IIA-LE is composed of 0.05% (w/v) Tan IIA, 20% (w/v) soybean oil–MCT mixture (1:1, w/w), 1.2% (w/v) soybean lecithin, 0.3% (w/v) F68 and 2.2% (w/v) glycerol, a high pressure homogenization at 100MPa for 3 cycles was selected as the optimal homogenization process. The Tan IIA-LE was light-sensitive but stable for at least 12 months at room temperature in dark. The safety study demonstrated that the Tan IIA-LE did not cause venous irritation or obvious acute toxicity. Furthermore, the Tan IIA-LE displayed significant anti-tumor activity against human hepatoma cell lines in vitro. Overall, the Tan IIA-LE developed in this study was suggested to be a suitable and safe dosage form of Tan IIA for intravenous administration and has potential in liver cancer therapy in future. [Copyright &y& Elsevier]

Read More
 
© 2012 Academic Articles
Some items on this website are used by permission granted in the Fair Use guidelines of the 1976 U.S. Copyright Act.